BIOMAT Database Logo BIOMAT Database Logo

A hybrid artificial liver system. Function of cultured monolayer pig hepatocytes in plasma from hepatic failure patients. 1991

J Uchino, and H Matsue, and M Takahashi, and Y Nakajima, and M Matsushita, and T Hamada, and E Hashimura
First Department of Surgery, Hokkaido University School of Medicine, Sapporo, Japan.

To produce a new hybrid artificial liver system, cultured pig hepatocytes were used in this study. Hepatocytes from normal healthy pigs were cultured in multiwell dishes. From the third day of cultivation, hepatocytes were divided into three groups according to the media used (Group 1, L-15; Group 2, normal human plasma; Group 3, plasma from hepatic failure [HF] patients). Measurements of cellular function of the cultured pig hepatocytes included metabolic activity (gluconeogenesis and ureogenesis), DNA content, and amino acid changes in the plasma. The ability to provide gluconeogenesis and ureogenesis by the cultured hepatocytes in HF plasma was maintained for 3 days, equal to that observed in Groups 1 and 2. DNA content was no different in the three groups. Elevated amino acid levels in the HF plasma, Phe, Met, Lys, and Gly, were significantly reduced by the cultured hepatocytes. The results indicate that the use of primary cultured pig hepatocytes is a step toward a hybrid artificial liver system, and a promising candidate as a bioreactor.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D005943 Gluconeogenesis Biosynthesis of GLUCOSE from nonhexose or non-carbohydrate precursors, such as LACTATE; PYRUVATE; ALANINE; and GLYCEROL.
D006501 Hepatic Encephalopathy A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5) Encephalopathy, Hepatic,Portosystemic Encephalopathy,Encephalopathy, Hepatocerebral,Encephalopathy, Portal-Systemic,Encephalopathy, Portosystemic,Fulminant Hepatic Failure with Cerebral Edema,Hepatic Coma,Hepatic Stupor,Hepatocerebral Encephalopathy,Portal-Systemic Encephalopathy,Coma, Hepatic,Comas, Hepatic,Encephalopathies, Hepatic,Encephalopathies, Hepatocerebral,Encephalopathies, Portal-Systemic,Encephalopathies, Portosystemic,Encephalopathy, Portal Systemic,Hepatic Comas,Hepatic Encephalopathies,Hepatic Stupors,Hepatocerebral Encephalopathies,Portal Systemic Encephalopathy,Portal-Systemic Encephalopathies,Portosystemic Encephalopathies,Stupor, Hepatic,Stupors, Hepatic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino

Related Publications

J Uchino, and H Matsue, and M Takahashi, and Y Nakajima, and M Matsushita, and T Hamada, and E Hashimura
[A hybrid artificial liver system composed of primary cultured canine hepatocytes].
February 1990, Nihon Geka Gakkai zasshi,
J Uchino, and H Matsue, and M Takahashi, and Y Nakajima, and M Matsushita, and T Hamada, and E Hashimura
[Metabolic evaluation of cultured porcine hepatocyte monolayers in human plasma from hepatic failure patients--basic study on development of a bioreactor in hybrid artificial liver].
July 1996, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
J Uchino, and H Matsue, and M Takahashi, and Y Nakajima, and M Matsushita, and T Hamada, and E Hashimura
Procurement of hepatocytes for a hybrid artificial liver.
January 1979, Transactions - American Society for Artificial Internal Organs,
J Uchino, and H Matsue, and M Takahashi, and Y Nakajima, and M Matsushita, and T Hamada, and E Hashimura
[Artificial system sustaining liver function in hepatic coma].
January 1978, Anesteziologiia i reanimatologiia,
J Uchino, and H Matsue, and M Takahashi, and Y Nakajima, and M Matsushita, and T Hamada, and E Hashimura
The viability and function of primary rat hepatocytes cultured on polymeric membranes developed for hybrid artificial liver devices.
June 2005, Journal of biomedical materials research. Part A,
J Uchino, and H Matsue, and M Takahashi, and Y Nakajima, and M Matsushita, and T Hamada, and E Hashimura
Evaluating the performance of a hybrid artificial liver support system with a recoverable hepatic failure rat model.
November 2001, Annals of the New York Academy of Sciences,
J Uchino, and H Matsue, and M Takahashi, and Y Nakajima, and M Matsushita, and T Hamada, and E Hashimura
Improved function of microencapsulated hepatocytes in a hybrid bioartificial liver support system.
August 1992, Artificial organs,
J Uchino, and H Matsue, and M Takahashi, and Y Nakajima, and M Matsushita, and T Hamada, and E Hashimura
Hybrid artificial liver support system for treatment of severe liver failure.
February 2005, World journal of gastroenterology,
J Uchino, and H Matsue, and M Takahashi, and Y Nakajima, and M Matsushita, and T Hamada, and E Hashimura
High metabolic function of primary human and porcine hepatocytes in a polyurethane foam/spheroid culture system in plasma from patients with fulminant hepatic failure.
January 2002, Cell transplantation,
J Uchino, and H Matsue, and M Takahashi, and Y Nakajima, and M Matsushita, and T Hamada, and E Hashimura
TECA hybrid artificial liver support system in treatment of acute liver failure.
December 2001, World journal of gastroenterology,
Copied contents to your clipboard!